Cite Filings / APRE / 0001104659-24-054473

Feed Companies Filings Check

Sign in

424B3

Prospectus

Aprea Therapeutics, Inc. Filed 2024-04-30 Acc 0001104659-24-054473

Documents 1

424B3 Prospectus , tm2410156-3_424b3.htm

Around this filing

2025-12-30 424B3 Prospectus
2024-05-02 4 Chief Medical Officer acquired 6,730 shares (grant or award)
2024-05-02 3 Initial Statement of Ownership
2024-04-30 424B3 Prospectus
2024-04-29 EFFECT Notice of Effectiveness
2024-04-25 CORRESP Correspondence Between Filers and SEC Staff
2024-02-09 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2410156-3_424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…